![Rob Henderson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Rob Henderson worked as the Director of Product Management at Corixa Corp.
He then served as the Chief Scientific Officer at Viridian Therapeutics, Inc. from 2021 to 2024.
Dr. Henderson obtained his undergraduate degree from the University of Virginia.
Anciens postes connus de Rob Henderson
Sociétés | Poste | Fin |
---|---|---|
VIRIDIAN THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2024 |
Corixa Corp.
![]() Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Corporate Officer/Principal | - |
Formation de Rob Henderson
University of Virginia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
VIRIDIAN THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Corixa Corp.
![]() Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |